Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$1.5M Buy
+926,157
New +$1.94M 0.76% 33
2025
Q1
Sell
-418,434
Closed -$2.84M 42
2024
Q4
$2.84M Sell
418,434
-81,566
-16% -$537K 1.2% 31
2024
Q3
$4.14M Buy
+500,000
New +$3.62M 1.65% 30

Other funds holding LUNG

Kent Lake PR's LUNG Position: Q3 2025 in Review

Kent Lake PR opened a new position in Pulmonx (LUNG) in Q3 2025: 926,157 shares worth $1.5M. The stake represents 0.76% of the portfolio and ranks #33 among its holdings. This is a return to the name: Kent Lake PR previously reported a position in LUNG as recently as Q4 2024.

Kent Lake PR first reported a position in LUNG in Q3 2024 and has held it in 3 quarters since. The position peaked at $4.14M in Q3 2024. 107 funds tracked by Wall St. Rank hold LUNG as of Q3 2025.

  • Kent Lake PR held 926,157 shares of Pulmonx worth $1.5M as of Q3 2025.
  • Pulmonx was a new Kent Lake PR position in Q3 2025.
  • Pulmonx made up 0.76% of Kent Lake PR's portfolio in Q3 2025, its #33 holding.
  • Kent Lake PR first reported a position in Pulmonx in Q3 2024 and has held it in 3 quarters since.
  • Kent Lake PR's Pulmonx position peaked at $4.14M in Q3 2024.
  • 107 funds tracked by Wall St. Rank held Pulmonx as of Q3 2025.

Based on Kent Lake PR's 13F filing for Q3 2025, filed 14 Nov 2025.